IP Library Granted Patent US 7,611,715
Granted Patent B2
US 7,611,715 · App. 11/737,709 · Granted Nov 3, 2009

Patent

Assignee: SSI Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,611,715
App. No.
11/737,709
Granted
Nov 3, 2009
Kind
B2
Abstract

A foodstuff capable of preventing the induction or metastasis of cancer is provided. In particular, an Agaricus blazei Murill extract comprising an ingredient capable of preventing the induction or metastasis of cancer is provided. The ingredient can be a chromatographic main elute fraction of 100 to 2000 molecular weight, obtained by the steps of extracting the fruit body of Agaricus blazei Murill with hot water, dialyzing the resultant extract, and subjecting the thus obtained dialysis external fluid to chromatography. Alternatively, the ingredient can be a dialysis external fluid obtained by the steps of extracting the fruit body of Agaricus blazei Murill with hot water, adding ethanol to the resultant extract to thereby obtain precipitates, dissolving the precipitates in water, and dialyzing the solution.

Claims (8)

1. A method for inhibiting induction of a cancer, metastasis of a cancer, or both, wherein the cancer is selected from lung or large intestine cancer, and wherein said cancer is caused by a carcinogen, said method comprising

administering a pharmacologically effective amount of extract from agaricus , wherein the extract is a chromatographic elute fraction of 100 to 2000 molecular weight obtained by the steps of extracting the fruit body of agaricus with water, dialyzing the resultant extract, and subjecting the thus obtained dialysis external fluid to chromatography.

2. A method for inhibiting induction of a cancer, metastasis of a cancer, or both, wherein the cancer is selected from lung or large intestine cancer, and wherein said cancer is caused by a carcinogen, said method comprising

administering a pharmacologically effective amount of extract from agaricus , wherein the extract is a dialysis external fluid obtained by the steps of extracting the fruit body of agaricus with water, adding ethanol to the resultant extract to thereby obtain precipitates, dissolving the precipitates in water, and dialyzing the solution.

3. The method according to claim 1 or claim 2 , wherein the cancer is induced by urethane (ethyl carbamate), NNK ((4-N-methyl-N-nitroamino)-1-(3-pyridyl)-1-buthanone) or azoxymethane.

4. A method for inhibiting metastasis of large intestine cancer wherein the cancer is caused by a carcinogen, said method comprising

administering a pharmacologically effective amount of extract from agaricus .

5. The method according to claim 4 , wherein the cancer is induced by urethane (ethyl carbamate), NNK ((4-N-methyl-N-nitroamino)-1-(3-pyridyl)-1-buthanone) or azoxymethane.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2012
From: KYOWA HAKKO BIO CO., LTD.
To: SSI CO., LTD.
Reel/Frame 028716/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2010
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA HAKKO BIO CO., LTD.
Reel/Frame 024252/0648 →
CHANGE OF NAME Recorded Apr 19, 2010
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 024252/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2009
From: KYOWA ENGINEERING CO., LTD.
To: KYOWA HAKKO KOGYO CO., LTD
Reel/Frame 023430/0917 →
Priority Claims (2)
JP 2002-193943 · Jul 2, 2002 · national
JP 2002-321864 · Nov 5, 2002 · national
Continuity (2)
Continuation 1051997100
Related Publication 20070184066A1 · Aug 9, 2007